Comparison of Current Diabetes Medication Use, Efficacy and Side Effects

Since the discovery and use of insulin in the 1930s, our understanding of diabetes and its pathogenesis has continued to grow, leading to a wide variety of diabetes treatment options worldwide. Advances in pharmaceutical chemistry over the past 50 years have significantly enriched the range of diabetes medications. This article examines the advantages and disadvantages of different diabetes medications, as well as the timing of their use. This article compares the hypoglycemic efficacy, mechanism of action, side effects, and precautions of three major diabetes medications: biguanides, sulfonylureas, and glinides. It also addresses the selection of diabetes medications in specific circumstances. Biguanides and sulfonylureas have roughly equivalent hypoglycemic effects and can be used in combination with other medications. However, biguanides are more susceptible to gastrointestinal side effects, while sulfonylureas are more prone to hypoglycemia. While glinides are less effective than the biguanides, they also have a lower risk of hypoglycemia. This systematic comparison of various diabetes medications based on their mechanism of action, efficacy, safety, and additional benefits, such as cardiovascular protection and weight management, aims to provide clinicians with a basis for precise, personalized medication decisions, highlight research gaps, and promote new drug development and overall patient management.